Teva Announces Approval of Generic Famvir Tablets

Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Novartis’ Famvir (Famciclovir) Tablets, 125 mg, 250 mg and 500 mg.
Business Wire